Shares of Eastman Kodak (NYSE: KODK) are up two-thirds so far this week after a special committee set up by the company’s board found no lawbreaking in controversial stock trades made by top management in the leadup to announcing a $765 million federal government loan to support a shift to pharmaceutical manufacturing.
Get the full story on our sister site Pharmaceutical Processing World.